Aura Biosciences Shares Rise After JMP Securities Initiation
1:22PM ET 7/19/2022 MT NewswiresAura Biosciences (AURA) shares rose about 5% in Tuesday afternoon trading after JMP Securities started the stock at market outperform and set the price...
Aura Biosciences (AURA) shares rose about 5% in Tuesday afternoon trading after JMP Securities started the stock at market outperform and set the price...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Aura Biosciences (AURA) said Thursday the US Food and Drug Administration granted a Fast Track designation for its bladder cancer drug candidate belzupacap...
Aura Biosciences (AURA) reported a Q4 net loss late Wednesday of $11.6 million, compared with a loss of $4.9 million a year earlier. Two analysts polled by...
Number of Employees | N/A |
Recent SEC Filing | 08/11/2022![]() |
Price Open | $18.55 |
Previous Close | $17.44 |
52 Week Range | $11.98 - 26.16 |
Market Capitalization | $555.9 M |
Shares Outstanding | 29.3 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 11/23/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$1.74 |
Beta vs. S&P 500 | N/A |
Revenue | N/A |
Net Profit Margin | N/A |
Return on Equity | -35.86% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |